As of May 04
| -2.17 / -1.39%|
The 18 analysts offering 12-month price forecasts for Amgen have a median target of 186.00, with a high estimate of 206.00 and a low estimate of 135.00. The median estimate represents a +20.64% increase from the last price of 154.18.
The current consensus among 24 polled investment analysts is to Buy stock in Amgen. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.